000566 海南海药
已收盘 05-15 15:00:00
资讯
新帖
简况
海南海药:公司根据规定在定期报告中披露相关股东人数
证券之星 · 05-12
海南海药:公司根据规定在定期报告中披露相关股东人数
5月7日海南海药发布公告,股东减持500万股
证券之星 · 05-07
5月7日海南海药发布公告,股东减持500万股
海南海药(000566)3月31日股东户数11.29万户,较上期减少3.91%
证券之星 · 04-28
海南海药(000566)3月31日股东户数11.29万户,较上期减少3.91%
海南海药:截至2026年3月31日公司股东户数为112,860
证券之星 · 04-21
海南海药:截至2026年3月31日公司股东户数为112,860
海南海药:公司盐酸沃尼妙林、头孢噻呋钠等8个兽药制剂获得批文
证券之星 · 04-17
海南海药:公司盐酸沃尼妙林、头孢噻呋钠等8个兽药制剂获得批文
海南海药:我司目前通过子公司海南海药投资有限公司持有上海优卡迪5.488%股权
证券之星 · 04-17
海南海药:我司目前通过子公司海南海药投资有限公司持有上海优卡迪5.488%股权
海南海药:制剂产品中有20个产品通过了仿制药一致性评价(或者视同通过)
证券之星 · 04-16
海南海药:制剂产品中有20个产品通过了仿制药一致性评价(或者视同通过)
海南海药:加速大健康类新品种市场导入
证券之星 · 04-16
海南海药:加速大健康类新品种市场导入
海南海药:创新采用“线上直播+线下商超+私域渠道”融合模式
证券之星 · 04-16
海南海药:创新采用“线上直播+线下商超+私域渠道”融合模式
海南海药:公司抗肝纤维化1类新药氟非尼酮胶囊III期临床已加速筹备中
证券之星 · 04-16
海南海药:公司抗肝纤维化1类新药氟非尼酮胶囊III期临床已加速筹备中
海南海药(000566)2025年年报简析:亏损收窄,短期债务压力上升
证券之星 · 04-12
海南海药(000566)2025年年报简析:亏损收窄,短期债务压力上升
海南海药(000566)3月31日股东户数11.29万户,较上期减少3.91%
证券之星 · 04-11
海南海药(000566)3月31日股东户数11.29万户,较上期减少3.91%
图解海南海药年报:第四季度单季净利润同比增长84.74%
证券之星 · 04-11
图解海南海药年报:第四季度单季净利润同比增长84.74%
海南海药(000566)披露出售股票资产公告,4月7日股价上涨1.31%
证券之星 · 04-07
海南海药(000566)披露出售股票资产公告,4月7日股价上涨1.31%
海南海药拟减持中国抗体不超5%股份
财中社 · 04-03
海南海药拟减持中国抗体不超5%股份
海南海药:截至2026年2月28日公司股东户数为122,506
证券之星 · 03-12
海南海药:截至2026年2月28日公司股东户数为122,506
股市必读:海南海药(000566)今年截至3月3日累计跌幅已超20%
证券之星 · 03-04
股市必读:海南海药(000566)今年截至3月3日累计跌幅已超20%
海南海药(000566)披露关于召开2026年第一次临时股东会的通知,2月25日股价上涨1.74%
证券之星 · 02-25
海南海药(000566)披露关于召开2026年第一次临时股东会的通知,2月25日股价上涨1.74%
海南海药(000566)2月10日股东户数12.45万户,较上期减少3.32%
证券之星 · 02-24
海南海药(000566)2月10日股东户数12.45万户,较上期减少3.32%
2月4日海南海药发布公告,股东减持342.73万股
中金财经 · 02-04
2月4日海南海药发布公告,股东减持342.73万股
加载更多
公司概况
公司名称:
海南海药股份有限公司
所属行业:
医药制造业
上市日期:
1994-05-25
主营业务:
海南海药股份有限公司的主营业务是药品研发、生产和销售。公司的主要产品是注射用头孢西丁钠、注射用头孢唑肟钠、注射用美罗培南、注射用氨曲南、注射用头孢呋辛钠、注射用头孢曲松钠、盐酸米诺环素胶囊、头孢克洛颗粒、头孢克洛干混悬剂、注射用头孢美唑钠、肠胃康系列(颗粒剂、片剂)、枫蓼肠胃康口服液、枫蓼肠胃康分散片、聚乙二醇4000散、富马酸伏诺拉生片、醋氨己酸锌胶囊、紫杉醇注射液、复方红豆杉胶囊、7-ANCA、4-AA、头孢西丁钠、头孢西丁酸、头孢唑肟钠、氨曲南、美罗培南、地氯雷他定口服溶液、注射用维生素C、小柴胡颗粒、红宝牌太和胶囊、双参活血通络颗粒、罗沙司他胶囊、利奈唑胺片、Crystaderm。
发行价格:
5.80
{"stockData":{"symbol":"000566","market":"SZ","secType":"STK","nameCN":"海南海药","latestPrice":4.58,"timestamp":1778828610000,"preClose":4.68,"halted":0,"volume":26718500,"delay":0,"changeRate":-0.0214,"floatShares":1297000000,"shares":1297000000,"eps":-0.3377,"marketStatus":"已收盘","change":-0.1,"latestTime":"05-15 15:00:00","open":4.68,"high":4.71,"low":4.58,"amount":124000000,"amplitude":0.0278,"askPrice":4.59,"askSize":414,"bidPrice":4.58,"bidSize":3824,"shortable":0,"etf":0,"ttmEps":-0.3377,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":4.68,"symbolType":"stock","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":5.15,"lowLimit":4.21,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1297365126,"isCdr":false,"pbRate":1365.21,"roa":"--","roe":"--","epsLYR":-0.3314,"committee":0.197812,"marketValue":5942000000,"turnoverRate":0.0206,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-05-18。","floatMarketCap":5939000000},"requestUrl":"/m/hq/s/000566","defaultTab":"news","newsList":[{"id":"2634521484","title":"海南海药:公司根据规定在定期报告中披露相关股东人数","url":"https://stock-news.laohu8.com/highlight/detail?id=2634521484","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634521484?lang=zh_cn&edition=full","pubTime":"2026-05-12 20:51","pubTimestamp":1778590276,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药(000566)05月11日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘及贵公司董事会成员,建议新董秘提升互动信披质量,不要敷衍了事。请问截止5月10日的股东人数?海南海药回复:您好,公司根据规定在定期报告中披露相关股东人数,敬请查阅已经披露的定期报告并关注后续披露的定期报告。谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200038060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0070","000566","BK0239","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144312","title":"5月7日海南海药发布公告,股东减持500万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144312","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633144312?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:01","pubTimestamp":1778155279,"startTime":"0","endTime":"0","summary":"证券之星消息,5月7日海南海药发布公告《海南海药:关于股东减持计划实施完成的公告》,其股东云南国际信托有限公司-聚利36号单一资金信托于2026年2月3日至2026年4月30日间合计减持500.0万股,占公司目前总股本的0.3854%,变动期间该股股价下跌19.48%,截止4月30日收盘报5.0元。股东增减持详情见下表:根据海南海药2026年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700037159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000566","BK0070","BK0239","BK0188","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630402374","title":"海南海药(000566)3月31日股东户数11.29万户,较上期减少3.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630402374","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630402374?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:42","pubTimestamp":1777369361,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海南海药披露,截至2026年3月31日公司股东户数为11.29万户,较3月10日减少4598.0户,减幅为3.91%。在化学制药行业个股中,海南海药股东户数高于行业平均水平,截至3月31日,化学制药行业平均股东户数为3.57万户。从股价来看,2026年3月10日至2026年3月31日,海南海药区间跌幅为5.23%,在此期间股东户数减少4598.0户,减幅为3.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800052281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","000566","BK0070","BK0188","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629031163","title":"海南海药:截至2026年3月31日公司股东户数为112,860","url":"https://stock-news.laohu8.com/highlight/detail?id=2629031163","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629031163?lang=zh_cn&edition=full","pubTime":"2026-04-21 20:48","pubTimestamp":1776775692,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药(000566)04月20日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘你好,请问截止2026年3月20日股东人数是多少?谢谢海南海药回复:您好,截至2026年3月31日公司股东户数为112,860。具体可参考公司近期披露的2025年年度报告。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100049847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","BK0146","BK0239","BK0070","000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628209968","title":"海南海药:公司盐酸沃尼妙林、头孢噻呋钠等8个兽药制剂获得批文","url":"https://stock-news.laohu8.com/highlight/detail?id=2628209968","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628209968?lang=zh_cn&edition=full","pubTime":"2026-04-17 20:51","pubTimestamp":1776430286,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药(000566)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,公司子公司重庆天地去年3月已经拿到了《兽药生产许可证》、《兽药GMP证书》,请问该子公司目前有没有开始生产兽药?海南海药回复:您好,公司盐酸沃尼妙林、头孢噻呋钠等8个兽药制剂获得批文,具体您可关注公司近期披露的2025年年度报告。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700043072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0239","BK0060","BK0146","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628113209","title":"海南海药:我司目前通过子公司海南海药投资有限公司持有上海优卡迪5.488%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2628113209","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628113209?lang=zh_cn&edition=full","pubTime":"2026-04-17 20:51","pubTimestamp":1776430277,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药(000566)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司参股上海优卡迪生物医药科技有限公司?该公司以CAR-T为主营,拥有多个CAR-T注册批件,请问公司持股多少?该公司和子公司海南优尼科尔有什么合作关系?若优卡迪后续IPO成功上市,能给公司带来什么收益?海南海药回复:您好,我司目前通过子公司海南海药投资有限公司持有上海优卡迪5.488%股权。其他事宜如有进展公司将根据相关规定履行信息披露义务,感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700043065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0070","BK0188","BK0239","BK0146","000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627213155","title":"海南海药:制剂产品中有20个产品通过了仿制药一致性评价(或者视同通过)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627213155","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627213155?lang=zh_cn&edition=full","pubTime":"2026-04-16 20:52","pubTimestamp":1776343970,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药(000566)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,请介绍一下目前贵公司所有产品过一致性评价情况,及再注册准备计划过评品种还有多少?海南海药回复:您好,制剂产品中有20个产品通过了仿制药一致性评价(或者视同通过),具体情况您可关注公司近期披露的2025年年度报告第三节 管理层讨论与分析之一、报告期内公司从事的主要业务,二、报告期内公司所处行业情况。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600041070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0070","000566","BK0146","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627460213","title":"海南海药:加速大健康类新品种市场导入","url":"https://stock-news.laohu8.com/highlight/detail?id=2627460213","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627460213?lang=zh_cn&edition=full","pubTime":"2026-04-16 20:52","pubTimestamp":1776343961,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药04月16日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600041061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","000566","BK0146","BK0060","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627213148","title":"海南海药:创新采用“线上直播+线下商超+私域渠道”融合模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2627213148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627213148?lang=zh_cn&edition=full","pubTime":"2026-04-16 20:52","pubTimestamp":1776343961,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药(000566)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,贵公司和新西兰AFT合作的大健康产品,有没有和头部视频直播卖货主播合作意向或者方式销售?海南海药回复:您好,公司将加速大健康类新品种市场导入,创新采用“线上直播+线下商超+私域渠道”融合模式,快速构建全渠道营销网络,推动产品快速渗透市场。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600041060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0070","BK0188","BK0060","BK0146","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627213195","title":"海南海药:公司抗肝纤维化1类新药氟非尼酮胶囊III期临床已加速筹备中","url":"https://stock-news.laohu8.com/highlight/detail?id=2627213195","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627213195?lang=zh_cn&edition=full","pubTime":"2026-04-16 20:52","pubTimestamp":1776343960,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药(000566)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,4月12日的权威财经报《财经参考网》披露贵公司新药氟非尼酮三期已于今年3月开首例患者入组?请问消息是否属实?海南海药回复:您好,公司抗肝纤维化 1 类新药氟非尼酮胶囊III期临床已加速筹备中。公司将根据进展情况及时履行信息披露义务,敬请广大投资者注意投资风险。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600041058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0070","BK0146","000566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626120276","title":"海南海药(000566)2025年年报简析:亏损收窄,短期债务压力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2626120276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626120276?lang=zh_cn&edition=full","pubTime":"2026-04-12 06:05","pubTimestamp":1775945131,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期海南海药发布2025年年报。本报告期海南海药短期债务压力上升,流动比率达0.31。其中,毛利率24.8%,同比减29.59%,净利率-54.88%,同比增65.91%,销售费用、管理费用、财务费用总计5.71亿元,三费占营收比68.66%,同比增0.25%,每股净资产0.06元,同比减84.43%,每股经营性现金流0.06元,同比增554.67%,每股收益-0.33元,同比增71.81%证券之星价投圈财报分析工具显示:业务评价:去年的净利率为-54.88%,算上全部成本后,公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0239","BK0060","BK0146","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626128090","title":"海南海药(000566)3月31日股东户数11.29万户,较上期减少3.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2626128090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626128090?lang=zh_cn&edition=full","pubTime":"2026-04-11 17:03","pubTimestamp":1775898218,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海南海药披露,截至2026年3月31日公司股东户数为11.29万户,较3月10日减少4598.0户,减幅为3.91%。在化学制药行业个股中,海南海药股东户数高于行业平均水平,截至3月31日,化学制药行业平均股东户数为3.45万户。从股价来看,2026年3月10日至2026年3月31日,海南海药区间跌幅为5.23%,在此期间股东户数减少4598.0户,减幅为3.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041100013115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0239","BK0188","BK0070","BK0060","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626114497","title":"图解海南海药年报:第四季度单季净利润同比增长84.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2626114497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626114497?lang=zh_cn&edition=full","pubTime":"2026-04-11 00:48","pubTimestamp":1775839728,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药2025年年报显示,当年度公司主营收入8.31亿元,同比下降16.1%;归母净利润-4.3亿元,同比上升71.81%;扣非净利润-4.7亿元,同比上升60.64%;其中2025年第四季度,公司单季度主营收入1.91亿元,同比上升2.97%;单季度归母净利润-1.88亿元,同比上升84.74%;单季度扣非净利润-1.98亿元,同比上升79.05%;负债率97.9%,投资收益-441.96万元,财务费用1.92亿元,毛利率24.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041100001188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625554939","title":"海南海药(000566)披露出售股票资产公告,4月7日股价上涨1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625554939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625554939?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:34","pubTimestamp":1775554458,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘,海南海药报收于5.4元,较前一交易日上涨1.31%,最新总市值为70.06亿元。近日,海南海药股份有限公司发布《关于出售股票资产的公告》。公告显示,公司拟通过集中竞价交易及大宗交易方式减持其持有的中国抗体制药有限公司股份,合计不超过6800万股,占其总股本比例不超过5%。公司持有中国抗体15888.21万股,占总股本的11.46%,股份权属清晰,不存在质押、冻结等情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0146","BK0070","BK0188","BK0239","000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624500126","title":"海南海药拟减持中国抗体不超5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2624500126","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624500126?lang=zh_cn&edition=full","pubTime":"2026-04-03 20:57","pubTimestamp":1775221020,"startTime":"0","endTime":"0","summary":"4月3日,海南海药(000566)发布公告,公司拟通过集中竞价交易及大宗交易的方式减持中国抗体(03681)股份数量不超过6800万股,不超过公司总股本的5%。截至公告披露日前一交易日,公司持有中国抗体1.59亿股股票资产的市值约为2.8亿港元,此次交易旨在优化公司资产结构,提高资产流动性及使用效率。2025年前三季度,海南海药实现收入6.40亿元,归母净利润-2.42亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695191451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","03681","BK1574","000566","BK0060","BK0188","BK0070","BK0239","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618132294","title":"海南海药:截至2026年2月28日公司股东户数为122,506","url":"https://stock-news.laohu8.com/highlight/detail?id=2618132294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618132294?lang=zh_cn&edition=full","pubTime":"2026-03-12 20:51","pubTimestamp":1773319889,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药(000566)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘你好,请问截止2026年2月28日股东人数是多少?谢谢海南海药回复:您好,截至2026年2月28日公司股东户数为122,506。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200036753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","000566","BK0060","BK0070","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616332373","title":"股市必读:海南海药(000566)今年截至3月3日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332373","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616332373?lang=zh_cn&edition=full","pubTime":"2026-03-04 02:17","pubTimestamp":1772561832,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘,海南海药报收于5.61元,下跌3.28%,换手率3.22%,成交量41.73万手,成交额2.39亿元。来自交易信息汇总:前10个交易日主力资金累计净流出2.53亿元,期间股价累计下跌11.82%。交易信息汇总3月3日海南海药收盘报5.61元,跌3.28%,当日成交4173.45万元。该股已连续2日下跌,当年累计跌幅20.85%。当日资金流向:主力资金净流出1879.39万元,游资资金净流出1081.11万元,散户资金净流入2960.5万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400001276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0146","000566","BK0060","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614337110","title":"海南海药(000566)披露关于召开2026年第一次临时股东会的通知,2月25日股价上涨1.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614337110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614337110?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:30","pubTimestamp":1772029848,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘,海南海药报收于6.45元,较前一交易日上涨1.74%,最新总市值为83.68亿元。近日,海南海药股份有限公司披露《关于召开2026年第一次临时股东会的通知》。公告显示,公司将于2026年3月13日召开2026年第一次临时股东会,会议由董事会召集,现场会议时间为当日15:00,网络投票时间为同日9:15至15:00。相关议案已获第十一届董事会第三十一次会议审议通过。关联股东需回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500038220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0070","BK0146","000566","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613782799","title":"海南海药(000566)2月10日股东户数12.45万户,较上期减少3.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613782799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613782799?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:19","pubTimestamp":1771924764,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海南海药披露,截至2026年2月10日公司股东户数为12.45万户,较1月31日减少4272.0户,减幅为3.32%。在化学制药行业个股中,海南海药股东户数高于行业平均水平,截至2月10日,化学制药行业平均股东户数为3.43万户。从股价来看,2026年1月31日至2026年2月10日,海南海药区间跌幅为0.93%,在此期间股东户数减少4272.0户,减幅为3.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400032256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0070","BK0239","BK0060","BK0146","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608633143","title":"2月4日海南海药发布公告,股东减持342.73万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608633143","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608633143?lang=zh_cn&edition=full","pubTime":"2026-02-04 19:16","pubTimestamp":1770203794,"startTime":"0","endTime":"0","summary":"证券之星消息,2月4日海南海药发布公告《海南海药:简式权益变动报告书(云南国际信托有限公司-聚利36号单一资金信托)》,其股东云南国际信托有限公司-聚利36号单一资金信托于2026年2月2日合计减持342.73万股,占公司目前总股本的0.2642%,变动期间该股股价下跌3.87%,截止2月2日收盘报6.21元。股东增减持详情见下表: 根据海南海药2025年三季报公布的十大股东详情如下: 为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202602/04/20260204931582.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202602/04/20260204931582.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260204/31998547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0070","BK0239","BK0060","BK0188","000566","BK0146"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778883899767,"stockEarnings":[{"period":"1week","weight":-0.0931},{"period":"1month","weight":-0.1627},{"period":"3month","weight":-0.2625},{"period":"6month","weight":-0.3235},{"period":"1year","weight":-0.1565},{"period":"ytd","weight":-0.3594}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南海药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"112860人(较上一季度减少3.91%)","perCapita":"11489股","listingDate":"1994-05-25","address":"海南省海口市秀英区南海大道192号","registeredCapital":"129736万元","survey":" 海南海药股份有限公司的主营业务是药品研发、生产和销售。公司的主要产品是注射用头孢西丁钠、注射用头孢唑肟钠、注射用美罗培南、注射用氨曲南、注射用头孢呋辛钠、注射用头孢曲松钠、盐酸米诺环素胶囊、头孢克洛颗粒、头孢克洛干混悬剂、注射用头孢美唑钠、肠胃康系列(颗粒剂、片剂)、枫蓼肠胃康口服液、枫蓼肠胃康分散片、聚乙二醇4000散、富马酸伏诺拉生片、醋氨己酸锌胶囊、紫杉醇注射液、复方红豆杉胶囊、7-ANCA、4-AA、头孢西丁钠、头孢西丁酸、头孢唑肟钠、氨曲南、美罗培南、地氯雷他定口服溶液、注射用维生素C、小柴胡颗粒、红宝牌太和胶囊、双参活血通络颗粒、罗沙司他胶囊、利奈唑胺片、Crystaderm。","listedPrice":5.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海南海药,000566,海南海药股票,海南海药股票老虎,海南海药股票老虎国际,海南海药行情,海南海药股票行情,海南海药股价,海南海药股市,海南海药股票价格,海南海药股票交易,海南海药股票购买,海南海药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}